Atlas FDA

VICI VENOUS STENT System

FDA premarket approval P180013/S002 · decided 2020-09-15

Approval details

PMA number
P180013
Supplement
S002
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
VICI VENOUS STENT System
Generic name
Stent, iliac vein
Applicant
Boston Scientific Corporation
Date received
2019-11-18
Decision date
2020-09-15
Days to decision
302 days
Decision code
APPR
Product code
QAN
Advisory committee
Cardiovascular
Expedited review
No
Location
Marborough, MA
Statement
Approval for a manufacturing site located at Confluent Medical, Free Zone and Business Park El Coyol, Building B14 Alajuela, Costa Rica for VICI stent component manufacturing.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
TheraSphere 360™ Y-90 Management Platform (K262462)Boston Scientific Corporation2026-07-24
FARADRIVE™ Steerable Sheath (M004PF21M402) (K262165)Boston Scientific Corporation2026-07-24
OBSIDIO Conformable Embolic (K261488)Boston Scientific Corporation2026-07-24
WallFlex Esophageal Stent System;Agile Esophageal Over-the-Wire (OTW) Stent System (K261978)Boston Scientific Corporation2026-07-10
RIVOS™ EUS Access Device (M00553900) (K260428)Boston Scientific Corporation2026-06-17
MOSES Raydar™ (K260100)Boston Scientific Corporation2026-05-18
TruSelect™ 2.6 Microcatheter (K260771)Boston Scientific Corporation2026-05-15
Asurys Fluid Management System (K251273)Boston Scientific Corporation2026-03-27